Indefinite Delivery Contract HT942524D0009
Award Date
8/23/24
Last Date to Order
9/2/29
Federal Agency
Defense Health Agency
Awardee
Leinco Technologies, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded Eli Lilly and Company a single award, indefinite delivery contract with a potential value of $2.4 billion to procure monoclonal antibody treatments. Three firm fixed price delivery orders have been issued against this contract vehicle to date, totaling over $1.8 billion, to supply monoclonal antibody products in support of the national interest action code for Coronavirus COVID-19. The initial...
This indefinite delivery contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the U.S. Department of Health and Human Services (HHS). The IDC has a ceiling value of $44,440,563.00 and a period of performance from September 2, 2015 to September 30, 2023. The primary purpose of this IDC is to support the development of Regeneron's anti-Ebola antibody therapeutics program. Regeneron Pharmaceuticals Inc., a for-profit...
This Indefinite Delivery Contract (IDC) was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency, to One Lambda, Inc., a for-profit manufacturer of medical testing reagents and supplies. The $2.1 million single-award IDC covers the delivery of various human leukocyte antigen (HLA) typing and antibody screening reagents to support diagnostics, research protocols, and accreditation maintenance at the NIH Clinical Center through July 2025. No set-aside...
This Indefinite Delivery Contract (IDC) award, valued at up to $50,097,495, was made by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Mapp Biopharmaceutical, Inc., a biotechnology company specializing in antibody-based therapeutics and medical countermeasures against infectious diseases and biothreats. The contract aims to support the advanced research, development, and acquisition of medical countermeasures such as...
This federal Indefinite Delivery Contract (IDC) was awarded by the Defense Health Agency (DHA), a defense agency, to Leidos, Inc., a global technology and engineering solutions provider. The contract has a ceiling value of $102,214,375.31 and a period of performance through January 31, 2028. It is not associated with any small business set-asides. The contract aims to provide meeting, programmatic, and administrative support services to the Congressionally Directed Medical Research Programs...
The Other Transaction IDV was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense on March 1, 2021 to Kpmg LLP. The potential value of the IDV is $44,737,893.71. The IDV aims to procure monoclonal antibody therapeutics infusion capacity for COVID-19. Specifically, the IDV seeks to establish prototype projects for monoclonal antibody therapeutics to treat COVID-19 infections. These prototype projects will work to rapidly produce monoclonal...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense has awarded a $10.5 million Other Transaction Indefinite Delivery Vehicle (IDV) to The Methodist Hospital Research Institute Division, a nonprofit academic medical research organization. The purpose of this IDV is to develop and deploy a novel "Antibody Accelerated Engineering by a Universal Selection (ANTAEUS)" platform, which will enable rapid identification and optimization of...
The provided information describes an Indefinite Delivery Contract (IDC) awarded by the Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response, to the prime contractor Elusys Therapeutics Inc. The contract has a total ceiling value of $69,586,152.55 and a period of performance ending on April 25, 2022. The contract is focused on Research and Development Facilities, with the prime contractor providing a range of biomedical products and...
This indefinite delivery contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Glaxosmithkline, LLC, a pharmaceutical company, to provide a portfolio of new antibacterial drugs for hospital and biothreat pathogens. The single-award IDC has a ceiling value of $255,851,502.87 and a period of performance through September 30, 2029. The contract aims to procure a range of pharmaceutical products and services from...
Emory University was awarded a single-award indefinite delivery contract by the Defense Health Agency (DHA) to provide services for the generation of monoclonal antibodies (mAbs) for the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The contract has a potential value of $763,502 and runs through September 2025. Under this IDV, Emory has received two firm fixed price delivery orders to date. The first, valued at $309,001, is for clinical trial research services...